| Schedule of the computation of basic and diluted net loss per share of Common Stock |
The following table sets forth the computation of basic and diluted net loss per share of common stock and preferred stock for the three months ended March 31, 2020 and 2019, which includes both classes of participating securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2020 |
|
|
Common stock |
|
Preferred stock |
|
|
Continuing Operations |
|
Discontinued Operations |
|
Continuing Operations |
|
Discontinued Operations |
Numerator: |
|
|
|
|
|
|
|
|
Allocation of undistributed net (loss) income |
|
$ |
(19,204,480 |
) |
|
$ |
899,476 |
|
|
$ |
(2,950,284 |
) |
|
$ |
138,182 |
|
Denominator: |
|
|
|
|
|
|
|
|
Weighted average shares |
|
53,934,760 |
|
|
53,934,760 |
|
|
1,657,143 |
|
|
1,657,143 |
|
Basic and diluted net (loss) income per share |
|
$ |
(0.36 |
) |
|
$ |
0.02 |
|
|
$ |
(1.78 |
) |
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2019 |
|
|
Common stock |
|
Preferred stock |
|
|
Continuing Operations |
|
Discontinued Operations |
|
Continuing Operations |
|
Discontinued Operations |
Numerator: |
|
|
|
|
|
|
|
|
Allocation of undistributed net loss |
|
$ |
(3,835,249 |
) |
|
$ |
(1,702,538 |
) |
|
$ |
(1,327,125 |
) |
|
$ |
(589,136 |
) |
Denominator: |
|
|
|
|
|
|
|
|
Weighted average shares |
|
41,284,168 |
|
|
41,284,168 |
|
|
2,857,143 |
|
|
2,857,143 |
|
Basic and diluted net loss per share |
|
$ |
(0.09 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.46 |
) |
|
$ |
(0.21 |
) |
|
| Schedule of anti-dilutive securities excluded from computation of diluted weighted shares outstanding |
The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2020 and 2019, as they could have been anti-dilutive:
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, |
|
|
2020 |
|
2019 |
Stock options |
|
7,712,680 |
|
4,345,305 |
Warrants on common stock |
|
4,024,708 |
|
4,024,708 |
Restricted Stock Units |
|
267,500 |
|
345,000 |
Underwriters' unit purchase option |
|
40,000 |
|
40,000 |
|